GGrantIndex
Sort

64,565 grants matching drug discovery

Design and Study of New Nicotinic Analogs for Use in Depression

$861,780
Alan P. Kozikowski · University Of Illinois At Chicago · U19 · FY2012 · MH

New Signaling Networks in Vascular Smooth Muscle

$861,613
Avril V. Somlyo · University Of Virginia · R01 · FY2023 · HL

New Signaling Networks in Vascular Smooth Muscle

$861,613
Avril V. Somlyo · University Of Virginia · R01 · FY2021 · HL

NOVEL STRATEGIES FOR PLANT-DERIVED ANTICANCER AGENTS

$861,604
University Of Illinois At Chicago · U19 · FY2001 · CA

A Novel Assay to Improve Translation in Analgesic Drug Development

$861,479
Sidney S Negus · Virginia Commonwealth University · R33 · FY2024 · NS

Catalytic and Regulatory Mechanisms of Heme-based Dioxygenases

$861,420
Syun-Ru Yeh · Albert Einstein College Of Medicine · R35 · FY2025 · GM

HLS-Cardiac Safety AI Trained Human Heart and Micro Heart Model

$861,204
Tetsuro Wakatsuki · Invivosciences, Inc. · R44 · FY2020 · HL

Development of IMPDH-Targeted Drugs against Crytosporidium

$861,098
Lizbeth K. Hedstrom · Brandeis University · U01 · FY2007 · AI

Mechanisms of Chromosome Maintenance in Bacteria

$861,097
Dhruba K Chattoraj · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Expanding small molecule functional metagenomics through shuttle BAC expression i

$861,013
Chengcang Charles Wu · Intact Genomics, Inc. · R44 · FY2015 · AI

Pediatric Heart Disease: Getting from Mutations to Therapeutics

$860,906
Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R35 · FY2018 · HL

Pediatric Heart Disease: Getting from Mutations to Therapeutics

$860,875
Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R35 · FY2019 · HL

Pediatric Heart Disease: Getting from Mutations to Therapeutics

$860,844
Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R35 · FY2020 · HL

Conservation and Sustainable Use of Biodiversity in PNG

$860,825
Louis R Barrows · University Of Utah · U01 · FY2010 · TW

Pediatric Heart Disease: Getting from Mutations to Therapeutics

$860,810
Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R35 · FY2021 · HL

Pediatric Heart Disease: Getting from Mutations to Therapeutics

$860,775
Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R35 · FY2022 · HL

Pediatric Heart Disease: Getting from Mutations to Therapeutics

$860,739
Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R35 · FY2023 · HL

BIOREPOSITORY OF HUMAN INDUCED PLURIPOTENT STEM CELLSFORCARDIOVASCULAR DISEASES (BHIPSC-CVD) - TASK AREA B

$860,651
Joseph Wu · Stanford University · N01 · FY2024 · HL

Near-IR Photorelease Chemistry: Discovery and Applications

$860,560
Martin Schnermann · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

ETIOLOGY OF SUBSTANCE USE IN AUSTRALIA /USA

$860,517
University Of Washington · R01 · FY2003 · DA

Live-Cell Fluorescence Lifetime FRET Assays for HTS

$860,487
Gregory David Gillispie · Fluorescence Innovations, Inc. · R42 · FY2015 · DA

AAA Proteins, Their Functions and Related Diseases

$860,316
Di S Xia · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Novel peptide-coated suture for cleft lip and palate repair

$860,274
Zhong Zheng · Scarless Laboratories, Inc. · R44 · FY2016 · DE

A novel approach to treat non-alcoholic steatohepatitis (NASH)

$860,261
Cynthia Arbeeny · Mitotherapeutix, Llc · R44 · FY2022 · DK

BioGRID: An Open Integrated Resource for Biological Interaction Data

$860,238
Michael David Tyers · Sinai Health System · R01 · FY2015 · OD